Brian Slomovitz and David M. Gershenson/LinkedIn
May 14, 2026, 17:13
Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
International Journal of Gynecological Cancer (IJGC), shared a post on LinkedIn:
”New IJGC Conversations episode!
Ribociclib+Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG3026 with Brian Slomovitz and David Gershenson
Tune in now.”
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 13, 2026, 15:58Sergei Gorlovetsky: Excited to Be Attending ESHRE 2026 in London as Part of Fertiligent AI
-
Jun 13, 2026, 15:50The Real Reason IVF Success Falls With Age – Fertility Plus
-
Jun 13, 2026, 15:15Marco Zaccaria: How to Use Power Doppler Ultrasound in Transvaginal Assessment of Uterine Fibroids
-
Jun 13, 2026, 14:42Nilofer Husain: ABHI Report Calls for Sustained Action on Women’s Health Inequalities
-
Jun 13, 2026, 14:29Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
-
Jun 12, 2026, 14:37ACOG Releases 2026 Maternal Immunization Schedule for Pregnant and Postpartum Patients – SMFM
-
Jun 12, 2026, 14:15Camille Clare: Representing Obstetrics and Gynecology at the AMA House of Delegates!
-
Jun 12, 2026, 14:13Amos Grünebaum: Balancing Autonomy and Safety in Freebirth Counseling!
-
Jun 12, 2026, 14:08Marco Zaccaria: How Do Elastic Centripetal Forces Lead to Dynamic Changes in the Myometrial Free Margin as Regards Submucous Myomas?